Risk factors and management of severe life-threatening anaphylaxis in patients with clonal mast cell disorders
about
2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines.H1-antihistamines for primary mast cell activation syndromes: a systematic review.Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease.Developments in the field of allergy in 2014 through the eyes of Clinical and Experimental Allergy.
P2860
Risk factors and management of severe life-threatening anaphylaxis in patients with clonal mast cell disorders
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Risk factors and management of ...... ith clonal mast cell disorders
@en
type
label
Risk factors and management of ...... ith clonal mast cell disorders
@en
prefLabel
Risk factors and management of ...... ith clonal mast cell disorders
@en
P2860
P356
P1476
Risk factors and management of ...... ith clonal mast cell disorders
@en
P2093
P2860
P304
P356
10.1111/CEA.12318
P50
P577
2014-07-01T00:00:00Z